Curebase
Curebase is a provider of decentralized clinical research software solutions and services to patients and medical providers.
Funding reportedLast round: Series B
What company datasets say Curebase raised
Funding, as reported
Reported in all57.6Min the source's currency
Rounds6
Last roundSeries B
Last round dateMay 2022
Investors listed15
Y CombinatorS18
Founders and team
From Curebase's own website: 3 on the team.
On 6 portfolio pages
Investors who name them
Breyer Capital
Acrew Capital
Notable Capital
Mount Pleasant Ventures
Future Planet Capital
Pascal Capital
Each firm lists Curebase on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.
Clinical Trials in the same market
Startups like it
Is this your company?
Add your raise, your deck and your story, and put Curebase in front of investors. Or tell us what we have wrong.